知识产权申办及组合管理
About
如果企业已经构思了顶尖的解决方案或推进技术的新方法，在与外界分享之前，甚至在全面投入到该创新之前，你有责任让团队和投资者与知识产权专业人员一起了解所需的保护措施，并制定战略，在市场上划定权利范围。飞翰的专业人员在知识产权法方面有数十年的丰富经验，能够在从想法到授权过程中，撰写可靠的专利以及制定有效的专利申请策略。而且我们不仅仅是帮助客户考虑单项发明。我们还帮助企业设计精密的知识产权协调组合，其中既包括均衡的分层专利和商业秘密，也涵盖商标和版权保护。
业务范围
PTAB上诉
专利审理与上诉委员会（PTAB）有权听取并裁断申请人对专利申请、专利再颁和复审程序中的不利判决而提出的上诉请求。
著作权
用德国、英国和美国知识产权法来保护企业和组织机构的版权作品，需要依赖对这些法律的清晰指导思路和创造性解决方案。这些指导和方案将帮助企业和组织机构在竞争中保持优势。
外观设计知识产权
企业的设计能将企业与竞争对手区分开来，使企业的产品与众不同，并有助于保持竞争优势。
知识产权组合管理
我们对现有的和发展中的组合进行评估，以确保商业计划依托且围绕着有强大知识产权保护以避免侵权的产品。这通常涉及查明并确定资产的优先级。
专利撰写与申办
要将创意转化为有价值的资产，企业需要训练有素的专业人员，从诉讼角度出发，以客户的利益和指示为重，战略性地起草和申请专利。
单方复审程序
根据《美国发明法案》，单方复审程序仍为挑战专利有效性的重要选项。
专利再颁
专利再颁程序是使专利权人当授权专利中出现的错误导致部分或全部专利无法实施或无效时，能够更正各种此类错误的程序。
专利期限延长(PTE)和补充保护证书(SPC)
补充保护证书(SPCs)可延长人用药和兽用药及植物保护产品（包括除草剂和杀虫剂）的专利保护期限，最长可达五年半。飞翰的欧洲律师在处理申请，成功获取英国和欧洲各国补充保护证书方面经验丰富。
标准必要专利 (SEP)
标准必要专利 (SEP) 是指被纳入某种技术标准的发明。处理 SEP 诉讼和许可谈判需要特殊的经验。
商业秘密
激烈的竞争、员工的流动性以及分拆企业和初创企业的激增使商业秘密保护变得至关重要。
商标咨询及申办
我们每年通常要提出数千条有关商标排查的意见。目前，我们负责25,000多项商标的申请与注册（美国和美国以外）。
经验
Finnegan is lead and preferred IP transactions counsel for one of the largest pharmaceutical companies in the world, handling more than 50 diligence projects each year, including all IP and related transactional aspects of the matters. The transactions span the full gamut of technologies from small molecule through biologics such as antibodies, oligonucleotides, and gene therapies. Finnegan also provides extensive assistance with post-deal integration procedures and subsequent global prosecution and portfolio strategy, ensuring a seamless transition of IP assets to the company and maximum value from acquired IP.
Finnegan is lead and preferred IP strategy counsel for one of the largest pharmaceutical companies in the world, handling all aspects of prosecution and portfolio management for multiple top-tier products for the client. The work spans the gamut from drafting and prosecution through larger strategic planning, patent term extension, and pre-litigation preparation on blockbuster small molecule and biologic products in the oncology, rheumatology, immunology, neuromuscular, and cell and gene therapy spaces.
IL-2024-000026, UK High Court
Finnegan is proud to partner with CentralSquare in developing and protecting its mission-critical software and technology solutions for public sector agencies, including those serving public safety and public administration. Our team has led the drafting and prosecution of a broad portfolio of artificial intelligence (AI)-related patent applications, advancing CentralSquare’s innovations across emergency services and municipal operations. These AI technologies accelerate emergency response, streamline workflows, and strengthen data-driven decision-making for agencies and the communities they serve.
Working closely with CentralSquare’s inventors and in-house counsel, we ensure every application captures the technical depth of the invention while aligning with CentralSquare’s strategic goals. We prioritize clarity, enforceability, and foresight—refining claims, anticipating examiner challenges, and crafting robust Office Action responses. By anticipating industry trends in AI and preparing forward-looking applications, Finnegan positions CentralSquare’s innovations not only to be protected, but to drive lasting impact in public safety and beyond.
